Detalhe da pesquisa
1.
Novel oral selective estrogen receptor degraders (SERDs) to target hormone receptor positive breast cancer: elacestrant as the poster-child.
Expert Rev Anticancer Ther;
24(6): 397-405, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38642015
2.
Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer.
NPJ Breast Cancer;
10(1): 27, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38605020
3.
Current and Emerging Role of Antibody-Drug Conjugates in HER2-Negative Breast Cancer.
Hematol Oncol Clin North Am;
37(1): 151-167, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36435607
4.
TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis.
Ther Adv Med Oncol;
15: 17588359231152844, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36743521